Rinat Hackmon

Dr. Rinat Hackmon


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2017 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
RHRinat Hackmon
Rinat Hackmon
LPLakmini Pinnaduwage
Lakmini Pinnaduwage
JZJianhong Zhang
Jianhong Zhang
SLStephen J. Lye
Stephen J. Lye
DGDaniel E. Geraghty
Daniel E. Geraghty
CDCaroline E Dunk
Caroline E Dunk

18 July 2022 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
CDCaroline E Dunk
Caroline E Dunk
MBMatthew Bucher
Matthew Bucher
JZJianhong Zhang
Jianhong Zhang
HHHeyam Hayder
Heyam Hayder
DGDaniel E. Geraghty
Daniel E. Geraghty
RHRinat Hackmon
Rinat Hackmon
The extravillous trophoblast expresses each of the nonclassical major histocompatibility complex class I antigens-human leukocyte antigens E, F, and G-and a single classical class I antigen, human leukocyte antigen C. We recently demonstrated dynamic expression patterns of human leukocyte antigens C, G, and F during early extravillous trophoblast invasion and placentation. This study aimed to investigate the hypothesis that the immune inflammatory mediated complications of pregnancy such as early preeclampsia and preterm labor may show altered expression profiles of nonclassical human leukocyte antigens. Real-time quantitative polymerase chain reaction, western blot, and immunohistochemistry were performed on placental villous tissues and basal plate sections from term nonlaboring deliveries, preterm deliveries, and severe early-onset preeclampsia, both with and without small-for-gestational-age neonates. Human leukocyte antigen G is strongly and exclusively expressed by the extravillous trophoblast within the placental basal plate, and its levels increase in pregnancies complicated by severe early-onset preeclampsia with small-for-gestational-age neonates relative to those of healthy term controls. Human leukocyte antigen C shows a similar profile in the extravillous trophoblast of preeclamptic pregnancies, but significantly decreases in the villous placenta. Human leukocyte antigen F protein levels are decreased in both extravillous trophoblast and villous placenta of severe early-onset preeclamptic pregnancies, both with and without small-for-gestational-age neonates, compared with those found in term and preterm birth deliveries. Human leukocyte antigen E decreases in blood vessels in placentas from preeclamptic pregnancies relative to its levels in term and preterm birth deliveries. Placental levels of human leukocyte antigens F and C are increased in cases of preterm birth with chorioamnionitis relative to those of cases of idiopathic preterm birth. Dysregulation of placental human leukocyte antigen expression at the maternal-fetal interface may contribute to compromised maternal tolerance in preterm birth with chorioamnionitis and excessive maternal systemic inflammation associated with severe early-onset preeclampsia.

1 September 2017 in Journal of Obstetrics and Gynaecology Canada
Verified
Journal Article
Closed access
RHRinat Hackmon
Rinat Hackmon
CLClifford Librach
Clifford Librach
RBRichard Burwick
Richard Burwick
NRNicole Rodrigues
Nicole Rodrigues
DFDan Farine
Dan Farine
HBHoward Berger
Howard Berger

1 September 2020 in Journal of Obstetrics and Gynaecology Canada
Verified
Journal Article
Closed access
KKKelly Kuo
Kelly Kuo
RSRosa Speranza
Rosa Speranza
RHRinat Hackmon
Rinat Hackmon

Verified
Journal Article
Open access
PDF file
RHRinat Hackmon
Rinat Hackmon
DGDan E. Geraghty
Dan E. Geraghty
CDCaroline E Dunk
Caroline E Dunk
Pregnancy is considered a unique immunological process in which contact between the maternal innate immune system and the placental allograft results in maternal tolerance to paternally derived antigens. A growing body of research indicates that interactions between non-classical placental Human Leukocyte Antigen (NCHLA) and receptors on decidual Natural Killer (dNK) cells from early implantation are crucial to this process. Preeclampsia (PE), one of the leading causes of maternal and fetal morbidity and mortality, is also considered an autoimmune process. Currently, there is no treatment for PE except delivery. Most adverse outcomes derive from delayed diagnosis, while newer preventative therapies significantly improve outcomes. An early predictor of PE would enable universal screening, detect and treat high-risk populations earlier, and improve outcomes. Recently, we discovered that high placental HLA-E and G expression occurs during early normal pregnancies, and that placental NCHLA expression differs in PE. Others described the HLA-E/G complex, a potent immunosuppressor of dNK. Interestingly, dNK cells were found to have memory-like properties in binding to HLA-G and HLA-E. The theory proposed is that the HLA-G complex plays a major role in the etiology of PE. In this narrative review, we examine the relevant literature and present our recent findings and those of others that suggest a screening model for PE.